Last 7 days
-10.8%
Last 30 days
-42.9%
Last 90 days
-59.9%
Trailing 12 Months
-78.4%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-01 | Cordova Ashley | sold | -19,264 | 21.8172 | -883 | chief financial officer |
2023-09-01 | Shah Pritesh | sold | -5,956 | 21.8172 | -273 | chief growth officer |
2023-09-01 | GROENHUYSEN WILHELMUS CM | sold | -6,414 | 21.8172 | -294 | chief operating officer |
2023-08-02 | Cordova Ashley | sold | -34,607 | 30.2511 | -1,144 | chief financial officer |
2023-06-30 | Weinberg Uri | acquired | 10,760 | 35.28 | 305 | chief innovation officer |
2023-06-30 | Shah Pritesh | acquired | 12,947 | 35.28 | 367 | chief growth officer |
2023-06-30 | Burke William Patrick | acquired | 12,595 | 35.28 | 357 | chief human resources officer |
2023-06-30 | Ben Arye Barak | acquired | 10,160 | 35.28 | 288 | general counsel |
2023-06-30 | Cordova Ashley | acquired | 12,947 | 35.28 | 367 | chief financial officer |
2023-06-30 | GROENHUYSEN WILHELMUS CM | acquired | 12,912 | 35.28 | 366 | chief operating officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-13 | CGC Financial Services, LLC | new | - | 1,245 | 1,245 | -% |
2023-09-12 | Farther Finance Advisors, LLC | new | - | 166 | 166 | -% |
2023-08-23 | WOLVERINE TRADING, LLC | new | - | 271,031 | 271,031 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.49 | -3,174,040 | 6,527,870 | 0.01% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | -1,766,000 | 3,934,000 | 0.04% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -4.56 | -163,918 | 312,290 | -% |
2023-08-16 | Nuveen Asset Management, LLC | reduced | -1.53 | -5,809,210 | 12,315,800 | -% |
2023-08-16 | Thomas J. Herzfeld Advisors, Inc. | sold off | -100 | -1,323 | - | -% |
2023-08-16 | Sunbelt Securities, Inc. | reduced | -36.17 | -1,492 | 1,245 | -% |
2023-08-15 | BENJAMIN F. EDWARDS & COMPANY, INC. | sold off | -100 | -8,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 13, 2023 | capital international investors | 7.8% | 8,155,909 | SC 13G/A | |
Feb 13, 2023 | capital world investors | 12.3% | 12,899,395 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.10% | 9,547,336 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.2% | 7,605,425 | SC 13G/A | |
Jan 23, 2023 | baillie gifford & co | 8.45% | 8,863,842 | SC 13G/A | |
Apr 11, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 11, 2022 | capital world investors | 12.3% | 12,723,214 | SC 13G/A | |
Feb 11, 2022 | capital international investors | 11.1% | 11,531,075 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 05, 2023 | 4 | Insider Trading | |
Sep 05, 2023 | 4 | Insider Trading | |
Sep 05, 2023 | 4 | Insider Trading | |
Sep 01, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 28, 2023 | 8-K | Current Report | |
Aug 04, 2023 | 4 | Insider Trading | |
Jul 27, 2023 | 8-K | Current Report | |
Jul 27, 2023 | 10-Q | Quarterly Report | |
Jul 21, 2023 | 8-K | Current Report | |
Jul 06, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 109.7B | 19.5B | 4.61% | 32.58% | 40.5 | 5.64 | 10.36% | 30.30% |
ISRG | 102.6B | 6.7B | 1.85% | 46.31% | 71.98 | 15.39 | 11.75% | -0.66% |
BSX | 78.2B | 13.4B | 7.30% | 33.81% | 85.79 | 5.84 | 8.69% | 3.17% |
BDX | 71.3B | 19.0B | -3.08% | 10.26% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 43.7B | 5.7B | -5.74% | -17.48% | 31.48 | 7.73 | 5.64% | -4.53% |
MID-CAP | ||||||||
PEN | 10.1B | 937.8M | 5.52% | 36.72% | 345.25 | 10.72 | 16.30% | 250.21% |
SWAV | 7.5B | 616.6M | -7.14% | -29.65% | 30.68 | 12.13 | 69.52% | 343.68% |
GMED | 5.3B | 1.1B | -4.57% | -12.56% | 25.23 | 4.84 | 12.63% | 50.85% |
IRTC | 2.7B | 452.1M | -16.85% | -42.51% | -27.51 | 6.04 | 24.99% | 24.09% |
TNDM | 1.5B | 790.3M | -18.06% | -57.30% | -6.6 | 1.87 | 3.21% | -1604.53% |
SMALL-CAP | ||||||||
ATEC | 1.6B | 421.8M | -8.54% | 49.60% | -9.62 | 3.81 | 44.49% | -2.43% |
AVNS | 952.1M | 780.7M | -7.00% | -11.88% | -26.45 | 1.22 | 4.68% | -510.17% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
SILK | 620.2M | 162.9M | -26.12% | -63.06% | -11.73 | 3.81 | 42.67% | 12.82% |
10.5%
-18.2%
-45.6%
99.6%
89.6%
53.5%
Y-axis is the maximum loss one would have experienced if Novocure was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -2.8% | 508 | 522 | 538 | 543 | 545 | 538 | 535 | 546 | 545 | 527 | 494 | 450 | 409 | 380 | 351 | 322 | 294 | 269 | 248 | 232 | 217 |
Gross Profit | -5.0% | 385 | 406 | 423 | 427 | 429 | 422 | 420 | 432 | 433 | 419 | 388 | 346 | 311 | 287 | 263 | 235 | 212 | 188 | 168 | 159 | 149 |
Operating Expenses | 3.8% | 576 | 555 | 512 | 497 | 483 | 467 | 464 | 441 | 419 | 385 | 357 | 328 | 304 | 285 | 264 | 245 | 230 | 215 | 202 | 189 | 179 |
S&GA Expenses | 7.3% | 201 | 187 | 174 | 163 | 154 | 144 | 137 | 129 | 126 | 121 | 118 | 113 | 108 | 103 | 97.00 | 91.00 | 86.00 | 82.00 | 78.00 | 72.00 | 70.00 |
R&D Expenses | -0.7% | 222 | 224 | 206 | 208 | 204 | 198 | 201 | 188 | 173 | 153 | 132 | 112 | 98.00 | 87.00 | 79.00 | 70.00 | 65.00 | 57.00 | 51.00 | 46.00 | 42.00 |
EBITDA | 100.0% | - | -102 | -63.54 | -64.17 | -51.21 | -41.26 | -41.72 | -7.60 | 15.00 | 36.00 | 36.00 | 29.00 | 21.00 | 16.00 | 13.00 | - | - | - | - | - | - |
EBITDA Margin | 100.0% | - | -0.20* | -0.12* | -0.12* | -0.09* | -0.08* | -0.08* | -0.01* | 0.03* | 0.07* | 0.07* | 0.06* | 0.05* | 0.04* | 0.04* | - | - | - | - | - | - |
Interest Expenses | 75.2% | 26.00 | 15.00 | 8.00 | -3.84 | -3.84 | -1.61 | 0.00 | 0.00 | 2.00 | 5.00 | 9.00 | 12.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | 13.00 | 12.00 | 12.00 |
Earnings Before Taxes | -23.4% | -160 | -130 | -81.85 | -74.86 | -61.98 | -51.86 | -52.07 | -17.68 | 4.00 | 21.00 | 18.00 | 8.00 | -2.05 | -6.15 | -8.82 | -18.06 | -27.00 | -36.90 | -45.94 | -42.01 | -42.44 |
EBT Margin | 100.0% | - | -0.25* | -0.15* | -0.14* | -0.11* | -0.10* | -0.10* | -0.03* | 0.01* | 0.04* | 0.04* | 0.02* | -0.01* | -0.02* | -0.03* | - | - | - | - | - | - |
Net Income | -23.7% | -174 | -140 | -92.53 | -81.69 | -68.24 | -58.87 | -58.35 | -26.98 | -4.57 | 12.00 | 20.00 | 19.00 | 12.00 | 9.00 | -7.23 | -27.12 | -40.74 | -54.98 | -63.56 | -58.87 | -58.68 |
Net Income Margin | 100.0% | - | -0.27* | -0.17* | -0.15* | -0.13* | -0.11* | -0.11* | -0.05* | -0.01* | 0.02* | 0.04* | 0.04* | 0.03* | 0.02* | -0.02* | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -4.61 | 9.00 | 20.00 | 24.00 | 36.00 | 59.00 | 106 | 113 | 99.00 | 84.00 | 40.00 | 24.00 | 22.00 | 16.00 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -1.3% | 1,159 | 1,174 | 1,192 | 1,174 | 1,163 | 1,150 | 1,139 | 1,120 | 1,097 | 1,068 | 1,052 | 431 | 529 | 502 | 479 | 444 | 406 | 370 | 340 | 316 | 310 |
Current Assets | -2.2% | 1,065 | 1,089 | 1,112 | 1,102 | 1,095 | 1,081 | 1,074 | 1,069 | 1,046 | 1,015 | 999 | 383 | 488 | 462 | 440 | 407 | 370 | 336 | 321 | 297 | 290 |
Cash Equivalents | -15.9% | 157 | 187 | 115 | 244 | 368 | 192 | 210 | 691 | 361 | 326 | 246 | 235 | 198 | 183 | 179 | 210 | 182 | 154 | 143 | 125 | 117 |
Inventory | 4.1% | 33.00 | 32.00 | 29.00 | 27.00 | 30.00 | 29.00 | 24.00 | 23.00 | 27.00 | 28.00 | 27.00 | 26.00 | 26.00 | 23.00 | 24.00 | 24.00 | 25.00 | 24.00 | 23.00 | 22.00 | 20.00 |
Net PPE | 12.9% | 41.00 | 36.00 | 33.00 | 30.00 | 27.00 | 25.00 | 23.00 | 12.00 | 12.00 | 12.00 | 11.00 | 10.00 | 11.00 | 10.00 | 9.00 | 8.00 | 8.00 | 8.00 | 8.00 | 9.00 | 9.00 |
Liabilities | 0.2% | 743 | 742 | 750 | 729 | 721 | 714 | 729 | 707 | 700 | 695 | 575 | 124 | 261 | 261 | 262 | 253 | 247 | 244 | 228 | 201 | 198 |
Current Liabilities | 0.9% | 150 | 149 | 159 | 141 | 135 | 128 | 143 | 125 | 116 | 110 | 114 | 95.00 | 85.00 | 84.00 | 86.00 | 80.00 | 74.00 | 71.00 | 65.00 | 48.00 | 45.00 |
LT Debt, Non Current | 0.1% | 567 | 566 | 566 | 565 | 564 | 563 | 562 | 561 | 561 | 560 | 430 | - | 150 | 149 | 149 | 149 | 149 | 149 | 149 | 149 | 149 |
Shareholder's Equity | -3.8% | 416 | 432 | 441 | 445 | 442 | 436 | 410 | 413 | 397 | 372 | 477 | 307 | 268 | 242 | 218 | 190 | 159 | 126 | 112 | 115 | 112 |
Retained Earnings | -6.9% | -888 | -831 | -778 | -741 | -714 | -690 | -685 | -659 | -646 | -631 | -631 | -635 | -645 | -646 | -650 | -655 | -657 | -655 | -643 | -628 | -616 |
Additional Paid-In Capital | 3.2% | 1,307 | 1,266 | 1,222 | 1,189 | 1,158 | 1,128 | 1,100 | 1,074 | 1,045 | 1,006 | 1,111 | 946 | 917 | 893 | 871 | 848 | 818 | 784 | 757 | 744 | 730 |
Shares Outstanding | 0.4% | 107 | 106 | 105 | 105 | 105 | 104 | 104 | 104 | 103 | 103 | 102 | 101 | 101 | 100 | 99.00 | 98.00 | 96.00 | 95.00 | 93.00 | 93.00 | 91.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -216.9% | -20.75 | 18.00 | 31.00 | 49.00 | 51.00 | 61.00 | 83.00 | 122 | 128 | 115 | 99.00 | 53.00 | 37.00 | 33.00 | 27.00 | 36.00 | 27.00 | 11.00 | -1.86 | -21.58 | -24.67 |
Share Based Compensation | 5.7% | 128 | 121 | 107 | 100 | 99.00 | 101 | 95.00 | 93.00 | 87.00 | 78.00 | 76.00 | 70.00 | 64.00 | 59.00 | 52.00 | 48.00 | 45.00 | 41.00 | 40.00 | 36.00 | 34.00 |
Cashflow From Investing | -421.4% | -209 | -40.26 | -139 | -510 | -58.04 | -216 | -144 | -259 | -414 | -415 | -472 | 94.00 | -55.36 | -53.79 | -51.67 | -6.70 | -5.53 | -4.62 | -5.49 | -5.65 | -6.40 |
Cashflow From Financing | 15.8% | 20.00 | 18.00 | 15.00 | 16.00 | 15.00 | 21.00 | 26.00 | 593 | 449 | 444 | 440 | -122 | 34.00 | 49.00 | 62.00 | 56.00 | 44.00 | 35.00 | 69.00 | 68.00 | 66.00 |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | |
Income Statement [Abstract] | |||||
Net revenues | $ 126,051 | $ 140,866 | $ 248,233 | $ 278,413 | $ 537,840 |
Cost of revenues | 34,018 | 28,503 | 63,632 | 56,230 | 114,867 |
Gross profit | 92,033 | 112,363 | 184,601 | 222,183 | 422,973 |
Operating costs and expenses: | |||||
Research, development and clinical studies | 55,427 | 57,075 | 115,131 | 99,309 | 206,085 |
Sales and marketing | 58,488 | 44,750 | 109,657 | 82,634 | 173,658 |
General and administrative | 40,778 | 31,666 | 82,722 | 62,174 | 132,753 |
Total operating costs and expenses | 154,693 | 133,491 | 307,510 | 244,117 | 512,496 |
Operating income (loss) | (62,660) | (21,128) | (122,909) | (21,934) | (89,523) |
Financial income (expenses), net | 8,756 | (2,228) | 17,925 | (3,937) | 7,677 |
Income (loss) before income tax | (53,904) | (23,356) | (104,984) | (25,871) | (81,846) |
Income tax | 3,514 | 652 | 5,495 | 2,784 | 10,688 |
Net income (loss) | $ (57,418) | $ (24,008) | $ (110,479) | $ (28,655) | $ (92,534) |
Basic net income (loss) per ordinary share (in usd per share) | $ (0.54) | $ (0.23) | $ (1.04) | $ (0.27) | $ (0.88) |
Diluted net income (loss) per ordinary share (in usd per share) | $ (0.54) | $ (0.23) | $ (1.04) | $ (0.27) | $ (0.88) |
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares) | 106,289,073 | 104,627,789 | 105,979,791 | 104,408,164 | 104,660,476 |
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares) | 106,289,073 | 104,627,789 | 105,979,791 | 104,408,164 | 104,660,476 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 156,978 | $ 115,326 |
Short-term investments | 783,837 | 854,099 |
Restricted cash | 516 | 508 |
Trade receivables, net | 70,988 | 86,261 |
Receivables and prepaid expenses | 20,148 | 25,959 |
Inventories | 33,023 | 29,376 |
Total current assets | 1,065,490 | 1,111,529 |
LONG-TERM ASSETS: | ||
Property and equipment, net | 41,156 | 32,678 |
Field equipment, net | 11,519 | 12,684 |
Right-of-use assets | 26,278 | 23,596 |
Other long-term assets | 14,572 | 11,161 |
Total long-term assets | 93,525 | 80,119 |
TOTAL ASSETS | 1,159,015 | 1,191,648 |
CURRENT LIABILITIES: | ||
Trade payables | 82,536 | 85,197 |
Other payables, lease liabilities and accrued expenses | 67,551 | 73,580 |
Total current liabilities | 150,087 | 158,777 |
LONG-TERM LIABILITIES: | ||
Long-term debt, net | 567,150 | 565,509 |
Deferred revenues | 807 | 2,878 |
Long-term leases | 20,329 | 18,762 |
Employee benefit liabilities | 4,840 | 4,404 |
Other long-term liabilities | 119 | 148 |
Total long-term liabilities | 593,245 | 591,701 |
TOTAL LIABILITIES | 743,332 | 750,478 |
COMMITMENTS AND CONTINGENCIES | ||
SHAREHOLDERS' EQUITY: | ||
Ordinary shares no par value, unlimited shares authorized; issued and outstanding: 106,605,331 shares and 105,049,411 shares at June 30, 2023 (unaudited) and December 31, 2022, respectively | 0 | 0 |
Additional paid-in capital | 1,306,603 | 1,222,063 |
Accumulated other comprehensive income (loss) | (1,981) | (2,433) |
Retained earnings (accumulated deficit) | (888,939) | (778,460) |
TOTAL SHAREHOLDERS' EQUITY | 415,683 | 441,170 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ 1,159,015 | $ 1,191,648 |